These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24937672)

  • 1. Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment response.
    Domanitskaya N; Wangari-Talbot J; Jacobs J; Peiffer E; Mahdaviyeh Y; Paulose C; Malofeeva E; Foster K; Cai KQ; Zhou Y; Egleston B; Hopper-Borge E
    Br J Cancer; 2014 Aug; 111(4):696-707. PubMed ID: 24937672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.
    Hopper-Borge EA; Churchill T; Paulose C; Nicolas E; Jacobs JD; Ngo O; Kuang Y; Grinberg A; Westphal H; Chen ZS; Klein-Szanto AJ; Belinsky MG; Kruh GD
    Cancer Res; 2011 May; 71(10):3649-57. PubMed ID: 21576088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7).
    Malofeeva EV; Domanitskaya N; Gudima M; Hopper-Borge EA
    Cancer Res; 2012 Dec; 72(24):6457-67. PubMed ID: 23087055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort.
    Sone K; Oguri T; Uemura T; Takeuchi A; Fukuda S; Takakuwa O; Maeno K; Fukumitsu K; Kanemitsu Y; Ohkubo H; Takemura M; Ito Y; Niimi A
    BMC Cancer; 2019 Mar; 19(1):246. PubMed ID: 30890141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
    Singel SM; Cornelius C; Batten K; Fasciani G; Wright WE; Lum L; Shay JW
    Clin Cancer Res; 2013 Apr; 19(8):2061-70. PubMed ID: 23479679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors.
    Zhang H; Patel A; Wang YJ; Zhang YK; Kathawala RJ; Qiu LH; Patel BA; Huang LH; Shukla S; Yang DH; Ambudkar SV; Fu LW; Chen ZS
    Mol Cancer Ther; 2017 Jun; 16(6):1021-1030. PubMed ID: 28265007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study.
    Kathawala RJ; Wei L; Anreddy N; Chen K; Patel A; Alqahtani S; Zhang YK; Wang YJ; Sodani K; Kaddoumi A; Ashby CR; Chen ZS
    Oncotarget; 2015 Jan; 6(1):510-21. PubMed ID: 25402202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
    Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K
    Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer.
    Oguri T; Ozasa H; Uemura T; Bessho Y; Miyazaki M; Maeno K; Maeda H; Sato S; Ueda R
    Mol Cancer Ther; 2008 May; 7(5):1150-5. PubMed ID: 18445659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammary ducts create a favourable microenvironment for xenografting of luminal and molecular apocrine breast tumours.
    Richard E; Grellety T; Velasco V; MacGrogan G; Bonnefoi H; Iggo R
    J Pathol; 2016 Nov; 240(3):256-261. PubMed ID: 27447842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
    Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
    Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.
    Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of breast tumor cell lines to predict for therapeutic response to microtubule-stabilizing agents.
    Kadra G; Finetti P; Toiron Y; Viens P; Birnbaum D; Borg JP; Bertucci F; Gonçalves A
    Breast Cancer Res Treat; 2012 Apr; 132(3):1035-47. PubMed ID: 21792624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance.
    Zhang H; Kathawala RJ; Wang YJ; Zhang YK; Patel A; Shukla S; Robey RW; Talele TT; Ashby CR; Ambudkar SV; Bates SE; Fu LW; Chen ZS
    Int J Biochem Cell Biol; 2014 Jun; 51():111-9. PubMed ID: 24726739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptome changes induced by docetaxel in human mammary cell lines expressing different levels of ERBB2.
    Dos Santos ML; Gimenes KP; Silva WA; Nagai MA
    Int J Mol Med; 2009 Jun; 23(6):733-43. PubMed ID: 19424599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.
    Smith MJ; Berger RW; Minhas K; Moorehead RA; Coomber BL
    Int J Exp Pathol; 2011 Apr; 92(2):106-16. PubMed ID: 21059124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts.
    Anbalagan M; Ali A; Jones RK; Marsden CG; Sheng M; Carrier L; Bu Y; Hangauer D; Rowan BG
    Mol Cancer Ther; 2012 Sep; 11(9):1936-47. PubMed ID: 22784709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer.
    Tan MH; De S; Bebek G; Orloff MS; Wesolowski R; Downs-Kelly E; Budd GT; Stark GR; Eng C
    Breast Cancer Res Treat; 2012 Feb; 131(3):849-58. PubMed ID: 21479552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
    Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer.
    Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R
    Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.